Skip to content

SBK Pharma

Active Risk: not assessed Private limited companyfounded 2022active for 4 yearsRoute de Ster 3, 4970 StavelotKBO/BCE: BE 0782.437.533

Board

1 director, since incorporation
Director (not named in the articles)
since 21-02-2022 term without a fixed end
listed in the 2025 annual accounts, filed on 16-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 23-02-2022

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Director (not named in the articles)
Board
Mandates as a list
    • Director (not named in the articles), from 21-02-2022 to date

Control

Founder
This company
SBK Pharma
Equity €43,628
Profit €8,967 in 2025

Capital

Contribution
€6,000
Shares
100
Contribution per share
€60
Equity per share
€436 in 2025
Source
deed of 23-02-2022

Articles of association

deed of 23-02-2022 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of June at 18:00

Shareholders

At incorporation deed of 23-02-2022 ↗
  • 100 shares (100%) · €6,000 in cash

Next steps